शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

INNOVACAPNSEInnova Captab Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 19 May, 2025 · 23:35 IST

Innova Captab Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

INNOVACAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.2%Reaction day
₹922.00
prior close
₹906.10
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.1%-0.1% vs market
Pharmaceuticals peers, median of 149sector-1.0%-0.1% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.2
10m
-1.9
15m
-2.7
30m
-1.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.2-1.1-0.1-1.0-0.1
Next day
-4.0-0.3-3.7-0.3-3.7
2d
-5.7-0.4-5.3-0.1-5.7
3d
-3.4+0.3-3.6-0.4-2.9
4d
-5.6+0.8-6.5+0.0-5.6
5d
-6.3+0.7-7.0-0.3-6.0
1w
-5.8+1.4-7.3+0.8-6.6
15d
-6.5+4.7-11.2+0.3-6.8
1m
-8.0+0.7-8.7-2.3-5.8
2m
-2.0+6.4-8.4+2.2-4.3
3m
-2.4+2.7-5.0-1.4-1.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Innova Captab Limited's board approved audited standalone and consolidated financial results for Q4 and FY25 on May 19, 2025. Consolidated revenue from operations grew to Rs. 1,243.68 crore in FY25 from Rs. 1,081.31 crore in FY24 (~15% growth), while profit after tax jumped to Rs. 128.26 crore from Rs. 94.35 crore (~36% growth). Basic EPS rose to Rs. 22.41 in FY25 from Rs. 18.66 in FY24. Statutory auditor BS R & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated results. The board also appointed new Secretarial Auditors (5-year term), Cost Auditor and Internal Auditor (Grant Thornton Bharat LLP) for FY26, approved shifting of the registered office, and cleared the notice for the 21st AGM.

Likely market impact

Strong earnings growth driven by higher revenue and improved operating leverage, with a clean audit opinion — positive for shareholder sentiment. No major red flags in the financials, though rising finance costs and a sharp jump in depreciation warrant monitoring.

By the numbersConsolidated · Q4 FY25 vs Q4 FY24
Q4 FY25Q4 FY24Change
Revenue₹314.7 Cr₹262.6 Cr+19.8%
Operating profit₹35.93 Cr₹33.86 Cr+6.1%
Profit after tax₹29.57 Cr₹28.72 Cr+3.0%
EBITDA margin15.2%14.5%+0.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.